PULMONARY ARTERIAL HYPERTENSION IN β-THALASSEMIA MAJOR PATIENTS: SYMPTOM & QUALITY OF LIFE IMROVEMENT AFTER TREATMENT WITH BOSENTAN

被引：0
|
作者：
Farmaki, K. [1 ]
Kolymbianaki, P. [1 ]
Tzoumari, I. [1 ]
Pappa, C. [1 ]
Kariofillis, P. [2 ]
Voudris, V. [2 ]
机构：
[1] Gen Hosp Corinth, Corinth, Greece
[2] Onassis Cardiac Surg Ctr, Dept Cardiol 22, Athens, Greece
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：765 / 765
页数：1
相关论文
共 50 条
  • [21] Pulmonary arterial hypertension treatment with bosentan in pediatric patients with congenital heart disease
    Romero Jimenez, Rosa M.
    Garcia Sanchez, Raquel
    Gimenez Manzorro, Alvaro
    Martinez Fernandez-Llamazares, Cecilia
    Sanjurjo Saez, Maria
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 347 - 347
  • [22] BUDGET IMPACT ANALYSIS OF BOSENTAN FOR TREATMENT OF PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Soto Molina, H.
    Diaz-Alvarez, O.
    Sandoval-Avila, M.
    VALUE IN HEALTH, 2018, 21 : S58 - S58
  • [23] Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: Impact of iloprost and bosentan treatment
    Dandel, Michael
    Lehmkuhl, Hans B.
    Mulahasanovic, Sead
    Weng, Yuguo
    Kemper, Dagmar
    Grauhan, Onnen
    Knosalla, Christoph
    Hetzer, Roland
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (09): : 898 - 906
  • [24] Palosuran Treatment Effective as Bosentan in the Treatment Model of Pulmonary Arterial Hypertension
    Pehlivan, Yavuz
    Dokuyucu, Recep
    Demir, Tuncer
    Kaplan, Davut Sinan
    Koc, Ibrahim
    Orkmez, Mustafa
    Turkbeyler, Ibrahim Halil
    Ceribasi, Ali Osman
    Tutar, Ediz
    Taysi, Seyithan
    Kisacik, Bunyamin
    Onat, Ahmet Mesut
    INFLAMMATION, 2014, 37 (04) : 1280 - 1288
  • [25] Palosuran Treatment Effective as Bosentan in the Treatment Model of Pulmonary Arterial Hypertension
    Yavuz Pehlivan
    Recep Dokuyucu
    Tuncer Demir
    Davut Sinan Kaplan
    Ibrahim Koc
    Mustafa Orkmez
    Ibrahim Halil Turkbeyler
    Ali Osman Ceribasi
    Ediz Tutar
    Seyithan Taysi
    Bunyamin Kisacik
    Ahmet Mesut Onat
    Inflammation, 2014, 37 : 1280 - 1288
  • [26] The addition of sildenafil to bosentan therapy in the treatment of pulmonary arterial hypertension
    Mathai, SC
    Fisher, MR
    Housten-Harris, T
    Girgis, RE
    Hassoun, PM
    CHEST, 2005, 128 (04) : 161S - 162S
  • [27] Bosentan, hope or reality for the treatment of pulmonary arterial hypertension - Reply
    de la Calzada, CS
    MEDICINA CLINICA, 2004, 123 (04): : 159 - 159
  • [28] Effect of bosentan treatment on surrogate markers in pulmonary arterial hypertension
    Souza, R
    Jardim, C
    Martins, B
    Cortopassi, F
    Yaksic, M
    Rabelo, R
    Bogossian, H
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (06) : 907 - 911
  • [29] Treatment of sarcoidosis-associated pulmonary arterial hypertension with Bosentan
    Bimenyuy, Christian
    Bourbonnais, Julie
    Samavati, Lobelia
    CHEST, 2007, 132 (04) : 482S - 483S
  • [30] Symptom Burden And Health-Related Quality Of Life In Pulmonary Arterial Hypertension
    Matura, L.
    McDonough, A.
    Carroll, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
12345